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 1 
Abstract 2 
 3 
Near-infrared spectroscopy (NIRS), measuring indocyanine green (ICG) after its peripheral 4 
venous injection, has been validated for minimally invasive measurement of relative muscle 5 
blood flow in fit young individuals, but not in COPD. Here we ask whether it could be used to 6 
evaluate respiratory and locomotor muscle perfusion in COPD patients. Vastus lateralis muscle 7 
blood flow (MBF, the reference method calculated from arterial and muscle ICG concentration 8 
curves) and a blood flow index (BFI, calculated using only the (same) muscle ICG 9 
concentration curves) were compared in 10 patients (FEV1:51±6%predicted) at rest and during 10 
cycling at 25%, 50%, 75% and 100% of WRpeak. Intercostal muscle MBF and BFI were also 11 
compared during isocapnic hyperpnea at rest, reproducing ventilation levels up to those at 12 
WRpeak. Intercostal and vastus lateralis BFI increased with increasing ventilation during 13 
hyperpnea (from 2.5±0.3 to 4.5±0.7nM/s) and cycling load (from 1.0±0.2 to 12.8±1.9nM/s), 14 
respectively. There were strong correlations between BFI and MBF for both intercostal 15 
(r=0.993 group mean data, r=0.872 individual data) and vastus lateralis (r=0.994 group mean 16 
data, r=0.895 individual data). Fold changes from rest in BFI and MBF did not differ for either 17 
the intercostal muscles or the vastus lateralis. Group mean BFI data showed strong 18 
interrelationships with respiratory and cycling workload, and whole body metabolic demand (r 19 
ranged from 0.913 to 0.989) simultaneously recorded during exercise. We conclude that BFI is 20 
a valid and minimally invasive tool for evaluating relative changes in respiratory and 21 
locomotor muscle perfusion from rest to peak exercise in COPD patient groups.  22 
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 33 
News and Noteworthy 34 
 35 
We show that non-invasive near-infrared spectroscopic (NIRS) detection of indocyanine green 36 
dye (ICG) after peripheral venous injection adequately reflects respiratory and locomotor 37 
muscle perfusion during exercise and hyperpnea in COPD patients. Mean, individual, and fold-38 
change responses from rest to exercise or hyperpnea correlated closely with the reference 39 
method, which requires arterial sampling. NIRS-ICG is a valid, robust and essentially non-40 
invasive tool for assessing relative changes in respiratory and locomotor muscle perfusion in 41 
COPD patient groups. 42 
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Introduction 120 
 121 
In patients with Chronic Obstructive Pulmonary Disease (COPD) restrictions in 122 
central hemodynamics owing to abnormal lung mechanics (18) can limit perfusion to the 123 
working muscles thereby exacerbating the competition between respiratory and locomotor 124 
muscles for the available blood flow (1, 5, 13). Measurement of muscle blood flow (MBF) 125 
in patients with COPD therefore provides an important tool for investigating the 126 
pathophysiological mechanisms involved in exercise intolerance and for assessing the 127 
effectiveness of pharmacological or non-pharmacological interventions.  128 
Methods for measuring MBF have been developed over the past 120 years (2). 129 
However, the traditional techniques for assessing MBF are highly invasive exposing the 130 
individuals to risks and posing difficulties to differentiate working and non working muscles 131 
(3). For example, by using NIRS after an intravenous injection of the light-absorbing tracer 132 
indocyanine green (ICG), it is possible to measure absolute values of MBF by applying the 133 
law of conservation of mass (3, 6). Specifically, the rate of accumulation of a tracer in a 134 
given tissue is equal to its rate of inflow minus its rate of outflow. If a tracer is introduced 135 
rapidly and its rate of accumulation is measured over time, blood flow can be measured as a 136 
ratio of the tracer accumulated to the quantity of tracer introduced over a given time. 137 
However, to measure the quantity introduced requires continuous arterial blood sampling 138 
over the time of tracer introduction, and thus the need for an indwelling arterial cannula. 139 
Recent studies indicate that in young, fit subjects, relative values of muscle blood flow 140 
can be determined by NIRS after intravenous ICG injection, measuring only the 141 
accumulation rate of tracer without arterial sampling (7, 8). The result, termed the blood 142 
flow index (BFI), was found to reliably reflect local (i.e., within the sampling volume of 143 
each NIRS optode) changes in both respiratory and locomotor MBF from rest to maximal 144 
ventilation (i.e., ~120 liters/minute) during (isocapnic) hyperpnea or during graded cycling 145 
exercise up to maximal levels (as high as 360 watts) (7, 8). However, the validity of this 146 
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method has not been investigated in a clinical population. Indeed, due to hemodynamic and 147 
muscular differences between healthy subjects and COPD patients (11, 18), the results 148 
obtained in healthy, fit subjects may not be transferrable to this patient population.  149 
To this end, we retrospectively analyzed data obtained in a representative population 150 
of COPD patients across a wide range of exercise intensities and rates of minute ventilation 151 
during cycling and subsequently during isocapnic hyperpnea (16). Accordingly, the purpose 152 
of the present study was to examine in COPD patients whether NIRS-ICG derived BFI 153 
reflects changes in respiratory and locomotor muscle perfusions as reliably as 154 
simultaneously determined MBF calculated by Fick principle based on the law of 155 
conservation of mass. 156 
Materials and methods 157 
Subjects 158 
We retrospectively analyzed data from ten clinically stable patients with COPD 159 
(FEV1:51±6% predicted) classified by the Global Initiative for Chronic Obstructive Lung 160 
Disease (GOLD, 2016) as stages II (n=4), III (n=3), and IV (n=3) from our previously 161 
published work (16). In the original study (16), vastus lateralis and intercostal muscle blood 162 
flow (MBF) were simultaneously measured in patients with COPD with the aim to 163 
investigate whether during exercise, intercostal MBF competes with locomotor muscles for 164 
the available blood flow (16). In the original study, only MBF data were analyzed and 165 
presented. In the present analysis, intercostal and vastus lateralis MBF are compared with 166 
simultaneously measured blood flow index (BFI) in the same locations. Measurements were 167 
made under two separate conditions: from rest to near-peak cycle exercise, and from resting 168 
to peak (isocapnic) hyperpnea. 169 
 170 
 171 
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Study Design 172 
The exercise protocols and isocapnic hyperpnea tests during which MBF and BFI were 173 
compared, as well as the methods used for assessing the physiologically relevant variables 174 
presented in this study, have been previously described (16), and are thus not repeated here.  175 
Intercostal and quadriceps MBF and BFI  176 
Absolute values of intercostal and vastus lateralis MBF during exercise were measured 177 
based on the principle of conservation of mass using an equation developed by (3). In brief, 178 
for both intercostal and vastus lateralis muscle, ICG concentration difference (measured by 179 
NIRS) at time t ([ICG]m) during dye accumulation in muscle tissue (between 10 and 70% of 180 
peak concentration) was divided by the integral under the arterial ICG concentration 181 
([ICG]a) curve (measured by linear photodensitometer) until time t and multiplied by t and a 182 
factor k for unit conversion as previously described (16):  183 
         Blood flow (ml/100ml/min-1) = 
 
 
m
t
a
o
k ICG t
ICG dt
 

  184 
Relative perfusion (BFI) of intercostal and vastus lateralis muscles during exercise 185 
was also obtained. This was done by dividing the NIRS-derived muscle ICG concentration 186 
difference (peak height of the ICG concentration curve) by the rise time from 10 to 90% of 187 
peak as previously described (7-9). NIRS-derived muscle ICG concentration was expressed 188 
in nanomoles per liter (nM). After dividing by the rise time (in seconds) the final unit of 189 
measurements of BFI was nM/s (7-9). Representative examples for calculating BFI for 190 
intercostal and vastus lateralis muscle from one individual are shown in Figure 1a and 191 
Figure 1b, respectively. ICG concentration curves were analyzed by using Chart5 v.5.4.2 192 
(ADInstruments) program (8). NIRS data were sampled at 6 Hz and time was synchronized 193 
to the metabolic, ventilatory, mechanical work and respiratory pressure data (16).   194 
 195 
 196 
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Statistical analysis  197 
Data are presented as means ± SEM. Pearson’s correlation coefficient (r) was used to 198 
establish associations between intercostal and vastus lateralis muscle BFI with MBF and 199 
other physiologically related variables. ANOVA with repeated measures and post-hoc 200 
comparisons (Tukey’s test) were used to identify statistically significant differences across 201 
the cycling exercise and isocapnic hyperpnea trials. Analysis of agreement between BFI and 202 
MBF measurements was performed by using Bland-Altman analysis. A satisfactory 203 
agreement between BFI and MBF was considered when the difference between BFI and 204 
MBF measurements did not significantly vary from 0 (zero). For this purpose one sample t-205 
test with testing variable the difference between BFI and MBF measurements and testing 206 
value 0 (zero) was performed. For Bland-Altman analysis purposes, both BFI in nM/s and 207 
MBF in ml/min/100g were expressed as fold changes from rest in order to allow a 208 
comparison between the two methods. The level of statistical significance was set at P < 209 
0.05. All statistical analyses were performed using the SPSS statistical software (v. 20 IBM 210 
SPSS Statistics, Chicago, IL, USA). 211 
 212 
Results 213 
Patient characteristics 214 
Detailed subject characteristics in terms of demographics, pulmonary function, and 215 
peak exercise performance data have been published and discussed previously (16). Not 216 
reported previously, patients exhibited impaired functional capacity in terms of the six 217 
minute walking distance test (389±31meters, 59±8% predicted), quadriceps muscle strength 218 
(28±5kg, 61±6% predicted), and quadriceps muscle endurance, (43±8 seconds 54±5% 219 
predicted, respectively).  220 
 221 
 222 
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Perfusion responses to exercise 223 
During the resting isocapnic hyperpnea trial, both intercostal muscle blood flow 224 
(MBF) and blood flow index (BFI) increased from: 7.0±0.6 to 11.4±1.3 ml/min/100gr 225 
(MBF) and from 2.5±0.3 to 4.5±0.7 nM/s, (BFI). Moreover, both MBF and BFI reached a 226 
plateau at 75% of peak minute ventilation (Figure 2a). During the cycling trial, both vastus 227 
lateralis MBF and BFI increased progressively with increasing power output: from 2.8±0.4 228 
to 39.7±7.0 ml/min/100gr (MBF) and from 1.0±0.2 to 12.8±1.9 nM/s, (BFI) up to 100% of 229 
WRpeak (Figure 2c). When MBF and BFI data were expressed as changes relative to flows 230 
at rest, the pattern of increase in muscle perfusion with cycle exercise or with resting 231 
hyperpnea did not significantly differ (between MBF and BFI) either for the intercostal or 232 
the vastus lateralis muscle groups (Figures 2b and 2d)    233 
Comparison of BFI and MBF 234 
During isocapnic hyperpnea, there was a highly significant and close correlation 235 
(r=0.993, P=0.001) between mean values of intercostal muscle BFI and MBF (Figure 3a). 236 
Furthermore, the individual values of intercostal muscle BFI and MBF showed a close linear 237 
relationship (r=0.872, P<0.001, Figure 3b). Normalization of BFI for body weight (BW), 238 
body mass index (BMI) and fat free mass index (FFMI) did not meaningfully change the 239 
correlation with MBF (r= 0.829, 0.856 and 0.837, P<0.001, respectively).   240 
During cycling exercise, the correlation between mean vastus lateralis muscle BFI and 241 
MBF was also close and highly significant (r=0.994, P=0.001, Figure 3c). Again, correlation 242 
analysis of individual patient vastus lateralis muscle BFI and MBF values showed close 243 
association between the two methods (r=0.895, P<0.001, Figure 3d). Normalization of BFI 244 
for BW, BMI and FFMI again did not meaningfully change the individual correlations with 245 
MBF (r=0.798, 0.843 and 0.809, P<0.001, respectively). Individual relationships between 246 
intercostal and vastus lateralis muscle BFI with intercostal and vastus lateralis MBF are 247 
shown in Figures 4 and 5, respectively. In addition, individual regression line slopes of the 248 
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individual relationships between intercostal and vastus lateralis muscle BFI and MBF are 249 
shown in Figure 6.   250 
Agreement between BFI and MBF 251 
Figure 7 shows the results of Bland-Altman analysis between MBF and BFI data 252 
expressed as fold change from rest for intercostal (Figure 7a) and vastus lateralis muscle 253 
groups (Figure 7b). Specifically, for both muscle groups there was a satisfactory agreement 254 
between MBF and BFI as the difference between the two methods in fold change from rest 255 
in muscle perfusion did not vary statistically significantly from 0 (zero) (intercostal muscles: 256 
mean difference: -0.05 fold change from rest, 95%CI: 0.07 to -0.17, p=0.424 and vastus 257 
lateralis: mean difference: -1.51 fold change from rest, 95%CI: -4.2 to 1.2, p=0.268, 258 
respectively).     259 
Associations between BFI and physiologically relevant variables 260 
During the isocapnic hyperpnea trial the mean change from rest in intercostal muscle 261 
BFI was linear with respect to the mean changes in whole body oxygen uptake (r=0.913, 262 
P=0.030), minute ventilation (r=0.954, P=0.012), the power of breathing (r=0.922, P=0.026), 263 
and tidal excursion in transdiaphragmatic pressure (r=0.962, P=0.009) (Figure 8). Similarly, 264 
the mean change from rest in vastus lateralis muscle BFI was linear with respect to mean 265 
change in whole body oxygen uptake (r=0.989, P=0.001, and mean cycling load (r=0.984, 266 
P=0.002) during graded cycling exercise (Figure 9). Individual r values for intercostal and 267 
vastus lateralis muscle between BFI and the aforementioned physiologically variables are 268 
shown in Table 1. Specifically, for the majority of patients, BFI increased linearly with 269 
physiological relevant variables, but the slope of the regression line varied considerably 270 
between subjects. 271 
 272 
 273 
 274 
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Discussion 275 
Main findings 276 
This study examined the validity of the essentially non-invasive NIRS-derived blood 277 
flow index (BFI) in reflecting respiratory and quadriceps muscle blood flow (MBF, the 278 
reference method) in a representative COPD population over a wide range of ventilation and 279 
exercise workloads. Under all conditions examined, individual, mean and fold change 280 
responses of BFI tracked MBF closely (Figures 2-5 and 7). Furthermore, while the slope of 281 
individual patient relationships between BFI and MBF may differ (Figure 6) individual 282 
correlations between the two methods for both intercostal and vastus lateralis muscle groups 283 
remained highly significant (Figure 3b and d and Figures 4 and 5). In addition, relative mean 284 
and individual changes in intercostal and vastus lateralis muscle BFI from rest to peak 285 
exercise or peak minute ventilation were strongly associated with measures of respiratory 286 
load, mechanical workload, and whole body metabolic demand across a wide range of 287 
physiologically relevant rates of minute ventilation and exercise intensities (Figures 8-9 and 288 
Table 1). 289 
The findings of the present study extend previous observations in young, fit 290 
individuals (6, 7) by demonstrating that BFI is able to detect changes in respiratory and leg 291 
MBF during exercise over a range of ventilation rates and exercise workloads typically 292 
experienced by patients with COPD. However, the BFI method does not allow absolute 293 
blood flow to be determined – it provides relative flow rates between conditions, but with 294 
the major advantage of avoiding arterial catheterization. 295 
Comparison of MBF to BFI 296 
This study provides strong support for the use of BFI in place of MBF as the data 297 
show. A difficulty in their comparison however is their very different units as explained in 298 
the Methods section. To compare side by side, we chose to calculate fold changes (from 299 
rest) in MBF and BFI, and these also indicated close similarity as shown (Figure 2b and 300 
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Figure 2d). However, fold changes are very sensitive to small variations in the resting values 301 
(which form the denominator for fold changes). This explains the behavior noted in the 302 
Bland-Altman plots (Figure 7) of some points with huge differences between the two 303 
methods - the points identified with asterisks towards the right side of Figure 7a and 7b. 304 
Specifically, for intercostal muscles (Figure 7a) one point lies at ~ +1-fold difference and 305 
two points at ~ -1 -fold difference whist for vastus lateralis muscle (Figure 7b) two points lie 306 
at ~ +20-fold difference and three at ~ -20 -fold difference, which seem to indicate very high 307 
variance. In Figures 4 and 5 we identify the same eight points, and it is apparent that the 308 
flows on exercise fit very well with the regression line in each case, reinforcing the 309 
sensitivity of fold-change to the resting data. The Bland-Altman plot therefore distorts the 310 
comparison of the MBF and BFI data because of the reliance on fold changes as the 311 
comparison variable. However, that plot remains useful as an indicator that mean values 312 
were not different from zero over the range encountered. 313 
Advantages of BFI for measuring muscle blood flow in COPD.  314 
BFI measures muscle blood flow by dividing the muscle ICG peak concentration 315 
(assessed noninvasively by NIRS-ICG curve) by the rise time from 10 to 90% of peak 316 
(Figure 1). The use of these two cutoff points eliminates the need for exact temporal 317 
definition of the start and end of the ICG washin, which are somewhat observer-dependent 318 
(7). The only invasive component of this technique - compared to traditional methods for 319 
assessing MBF - is peripheral venous bolus injection of the ICG tracer. BFI requires only 320 
the determination of the muscle ICG peak concentration and the times at 10% and 90% of 321 
the rise in ICG concentration (Figure 1) thus reducing the possibility of observer errors. 322 
Indeed, the study by Habazettl et al., (8) in normal subjects reported that the reproducibility 323 
of BFI is high as there is less inter-observer variability for analyses of intercostal and 324 
quadriceps muscle BFI compared to the variability observed during MBF calculation 325 
measured by NIRS-ICG relying on the Fick principle. Taking into consideration the 326 
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practical and methodological advantages of BFI as well as the findings of the present study 327 
showing that mean and individual values of BFI and MBF were strongly associated over a 328 
wide range of ventilatory rates and exercise intensities (Figures 2-5) we suggest that BFI can 329 
be considered a reliable measure of relative blood flow changes from rest to exercise in 330 
patients with COPD. 331 
Prior studies of the validation of the NIRS-ICG derived BFI 332 
In clinical populations NIRS-ICG derived BFI has been shown to be sensitive and 333 
reproducible in detecting relative perfusion differences in cerebral blood flow during 334 
bedside assessment in patients with acute ischemic stroke (9, 14, 19). Furthermore, a 335 
validation study in young, fit subjects by Habazettl et al. (8) compared BFI values within the 336 
vastus lateralis and 7th intercostal space against NIRS–ICG derived absolute MBF during 337 
cycling exercise up to a maximal level (~360 watt). The results indicated a strong group 338 
mean and individual agreement between BFI and MBF measured across both respiratory and 339 
quadriceps muscles. In addition, the study by Guenette et al. (7) extends the observation by 340 
Habazettl et al. (8) by investigating the sensitivity of BFI in intercostal and 341 
sternocleidomastoid muscles across a wide range of ventilatory rates up to maximal levels 342 
(i.e., ~120 liters/min) during an isocapnic hyperpnea trial with simultaneous measurements 343 
of electromyography and the work of breathing produced by these muscles. The results of 344 
that study showed a strong correlation with the work of breathing and electromyography 345 
(EMG) data for both aforementioned respiratory muscles (7).  346 
Relationship between BFI and other physiological variables 347 
In addition to the data comparing BFI to MBF, BFI was related to a number of 348 
physiologically relevant variables that were simultaneously recorded during the two 349 
protocols (i.e., cycling exercise and isocapnic hyperpnea trials). The strong group mean and 350 
individual associations that we found between BFI and those variables (Figures 8-9, Table 351 
1) further support the physiological value of BFI as an index proportional to exercise-related 352 
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variables. In addition, these associations are also useful because considering the 353 
comparisons between BFI and MBF, one could argue that a bias may occur owing to the 354 
mathematical coupling between BFI and MBF variables (12, 20). This is because calculation 355 
of both BFI and MBF use the same muscle ICG-concentration curve. Therefore, relating BFI 356 
to independent relevant variables provides additional support for its validity. There were 357 
strong linear relationships between intercostal and vastus lateralis BFI and metabolic 358 
requirement (VO2), ventilation, and mechanical loading (Figures 8-9 and Table 1) – 359 
relationships which avoid any mathematical coupling.  360 
BFI application to individual patients and to groups of patients 361 
The data show excellent reliability when average values for groups are to be compared 362 
(Figures 2, 3a and b). However it is more difficult to know whether BFI can be used to 363 
estimate MBF on a single patient basis. This is because while BFI is an index proportional to 364 
MBF, the slope of the BFI/MBF relationship varies across individuals (Figure 6). Therefore, 365 
one cannot convert BFI to actual MBF in all patients by a single assumed average 366 
proportionality constant (Figure 6). Figure 4 (Intercostals, hyperpnea trial), Figure 5 367 
(Quadriceps, cycling trial), and Figure 6 address this point by plotting for each of the 10 368 
patients the individual relationships (Figures 4-5) and the regression line slopes (Figure 6) 369 
between BFI and MBF. While in each case the relationships are closely linear for the 370 
intercostal muscles, for two patients (i.e., subjects 6 and 7, Figure 4) the slopes between BFI 371 
and MBF relationship differ considerably from the other 8 subjects (Figure 6a). It is of 372 
interest that for the same two subjects, the correlations between BFI and other 373 
physiologically relevant variables are also found to be weak (Table 1), suggesting a 374 
physiological rather than technical explanation. For the quadriceps (Figure 6b) the 375 
regression line slopes varied less as compared to intercostal muscles. In summary, 376 
intercostal and quadriceps BFI cannot be used for conversion to MBF in all individual 377 
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subjects under different conditions, although use of an average proportionality constant 378 
would be satisfactory for the majority of patients. 379 
Methodological considerations  380 
The present study assessed respiratory muscle BFI in COPD patients at the level of the 381 
7th intercostal space as this has been previously proposed for measuring absolute MBF by 382 
studies using the NIRS-ICG approach (6, 7, 10, 15-17). This site of measurement (i.e., 7th 383 
intercostal space), while easily accessible by NIRS, reflects both internal and external 384 
intercostals muscles, thus providing an overall assessment of respiratory MBF. However, it 385 
does not reflect diaphragm blood flow. Nevertheless, in COPD patients, as the degree of 386 
dynamic lung hyperinflation gradually increases during exercise, the pressure generated by 387 
the diaphragm decreases and the act of inspiration is more dependent on the rib cage 388 
inspiratory muscles such as the intercostal muscles (4). Indeed, in our study we did not find 389 
any impact of dynamic lung hyperinflation on intercostal muscle BFI responses as both 390 
progressively increased, leveling off at 75% of WRpeak during isocapnic hyperpnea (actual 391 
increase in end-expiratory lung volume at 25, 50, 75, 100% of WRpeak was 60±90, 240±50, 392 
550±110, 480±180 ml, respectively). This further supports the use of 7th intercostal space for 393 
assessing respiratory MBF in clinical populations irrespective of the occurrence of exercise-394 
induced dynamic hyperinflation.  395 
We found stronger associations between individual values of BFI and MBF (Figures 396 
3b and d) in both respiratory (r=0.872 and locomotor muscles (r=0.895) compared to those 397 
reported in young, fit subjects by Habazettl et al. (8) (i.e., r=0.730 and r=0.720, 398 
respectively). In fact, the study by Habazettl et al. (8) reported substantial scattering of 399 
individual data of BFI and MBF mostly exhibited during high levels of exercise. In our 400 
study, scattering of individual data of BFI and MBF appears much less with increasing 401 
exercise intensity (Figures 3b and d). This may be attributed to the lower peak ICG values 402 
that COPD patients exhibited compared to healthy subjects (both in muscle and arterial 403 
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blood) - as response to lower exercise intensity - and thus making easier to calculate the 404 
peak ICG concentrations. Indeed, determination of peak ICG concentrations may be a source 405 
of random errors that may contribute to the variability of individual BFI vs. MBF values (9), 406 
especially when oscillations of the ICG concentration curve due to strong muscle contraction 407 
dynamics during forced ventilation or high workloads require smoothing of the original ICG 408 
concentration curve (for example see figure 1). 409 
Another methodological consideration is the normalization of the BFI values for body 410 
mass/composition when major variability in body mass (BM) and/or composition exists 411 
(Habazettl et al., 2010). In our study we did not normalize as we were most interested in 412 
BFI/MBF relationships within each patient. However, we did analyze normalization of both 413 
intercostal and vastus lateralis muscle BFI to BM, BMI and fat-free mass index (FFMI). 414 
Although we found that BM, BMI and FFMI varied considerably among patients (i.e., BM: 415 
from 52 kg to 110 kg, BMI: from 18.4 to 34.7 kg/m2 and FFMI: from 17.5 to 23.1 kg/m2), 416 
this did not affect the level of association between the BFI and MBF in both muscle groups. 417 
Conclusions 418 
In a small population of patients with COPD, the essentially non-invasively derived 419 
BFI showed close agreement with MBF (determined from the same signals combined with 420 
arterial ICG concentration/time curves) when applied to group data. This was found for 421 
changes in intercostal and locomotor MBF across a wide range of ventilatory rates and 422 
exercise workloads up to peak levels. The findings support the quantitative validity of this 423 
method, thereby allowing for minimally invasive assessment of relative muscle blood flow 424 
in this population. While individual patient values of BFI and MBF were also generally 425 
similar in both muscle groups, occasional patients displayed variances which give rise to 426 
caution in application to individual patients. 427 
 428 
 429 
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Table 1. Regression analysis for individual subjects between BFI and physiologically relevant 
variables 
 
                 Intercostal muscles  
               (hyperpnea trial) 
 Quadriceps muscle 
(cycling trial) 
Patients BFI vs.VO2 BFI vs.VE BFI vs. PoB BFI vs. ΔPdi 
 
BFI vs.VO2 BFI  vs. Work 
1 0.909 0.953 0.962 0.961  0.937 0.958 
2 0.900 0.973 0.955 0.953  0.969 0.912 
3 0.915 0.949 0.891 0.893  0.895 0.937 
4 0.893 0.895 0.906 0.915  0.921 0.938 
5 0.710 0.713 0.568 0.559  0.698 0.541 
6 0.260 0.273 0.330 0.313  0.829 0.729 
7 0.686 0.493 0.289 0.328  0.903 0.927 
8 0.907 0.901 0.904 0.931  0.890 0.990 
9 0.925 0.942 0.958 0.959  0.989 0.970 
10 0.852 0.789 0.796 0.836  0.875 0.938 
 565 
 566 
Individual Pearson r values relating intercostal muscles blood flow index (BFI) oxygen 567 
uptake (VO2), minute ventilation (VE), power of breathing (PoB) and transdiaphragmatic 568 
pressure (ΔPdi) recorded from rest to peak minute ventilation during the isocapnic 569 
hyperpnea trial and quadriceps muscle blood flow index (BFI) with quadriceps muscle 570 
blood flow (MBF), oxygen uptake (VO2) and work (watts) recorded from rest to WRpeak 571 
during cycling exercise.  572 
 573 
 574 
 575 
 576 
 577 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
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Figure legends 591 
 592 
Figure 1. Representative examples of an intercostal (a) and quadriceps (b) muscle 593 
indocyanine green (ICG) concentration curve recorded by near-infrared spectroscopy 594 
(NIRS) during isocapnic hyperpnea and cycling trials at 75% of WRpeak in an individual 595 
subject. Isocapnic hyperpnea was sustained at the level of minute ventilation (i.e., 40 l/min) 596 
similar to that recorded during cycling exercise at 75% of WRpeak (i.e., 58 watts). The 597 
original tracing (gray line) appears with marked oscillations owing to muscle contraction 598 
and relaxation during exercise. Low-pass filtering with a cutoff frequency of 0.5 Hz 599 
produced the smoothed curve (black line) that was used for blood flow index (BFI) 600 
calculation. ICG concentrations expressed in nanomoles/liter (nM) and the rise time 601 
expressed in seconds between 10% and 90% of ICG concentration peak are indicated, and 602 
intercostal and quadriceps muscle BFI calculations and results are shown. 603 
 604 
Figure 2. Group mean responses of intercostal (a) and quadriceps (c) muscle blood flow 605 
(MBF) and blood flow index (BFI) during isocapnic hyperpnea and cycling trials 606 
respectively. Relative changes from rest of intercostal (b) and quadriceps (d) muscle blood 607 
flow (MBF) and blood flow index (BFI) are also shown. Data are presented as mean ± SEM. 608 
Asterisks denote significant differences from 100% of WRpeak, P<0.05. (MBF data were 609 
reproduced from reference 16).   610 
 611 
Figure 3. Comparison of mean and individual blood flow index (BFI) and muscle blood 612 
flow (MBF) values for intercostal (a) and (b) and quadriceps (c) and (d) muscles during 613 
isocapnic hyperpnea and cycling trials, respectively. Linear regression equations, regression 614 
coefficients, and significance levels are presented in each figure. (MBF data were 615 
reproduced from reference 16). 616 
 617 
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Figure 4. Individual patient correlations between intercostal muscle blood flow index (BFI) 618 
and intercostal muscle blood flow (MBF). Linear regression equations and regression 619 
coefficients are presented in each figure. (MBF data were reproduced from reference 16). 620 
 621 
Figure 5. Individual correlations between vastus lateralis muscle blood flow index (BFI) 622 
with vastus lateralis muscle blood flow (MBF). Linear regression equations and regression 623 
coefficients are presented in each figure. (MBF data were reproduced from reference 16). 624 
 625 
Figure 6. Individual regression line slopes between (a) intercostal muscle blood flow index 626 
(BFI) and intercostal muscle blood flow (MBF) and (b) vastus lateralis muscle blood flow 627 
index (BFI) with vastus lateralis muscle blood flow (MBF). Mean regression line slope and 628 
equation is presented in each figure (MBF data were reproduced from reference 16). 629 
 630 
Figure 7. Bland-Altman plots comparing fold changes form rest of intercostal (a) and 631 
quadriceps (b) muscle blood flow (MBF) and blood flow index (BFI) during isocapnic 632 
hyperpnea and cycling trials, respectively (MBF data were reproduced from reference 16).  633 
 634 
Figure 8. Regression analyses of mean intercostal muscle blood flow index (BFI) and (a) 635 
oxygen uptake, (b) minute ventilation, (c) power of breathing, and (d) tidal excursion in 636 
transdiaphragmatic pressure during the isocapnic hyperpnea trial. Regression coefficients 637 
and significance levels are presented in each figure. (physiologically relevant data were 638 
reproduced from reference 16).   639 
 640 
Figure 9. Regression analyses of mean quadriceps muscle blood flow index (BFI) and (a) 641 
oxygen uptake and (b) work rate recorded at rest and during the cycling trial. Regression 642 
 19 
 
coefficients and significance levels are presented in each figure. (physiologically relevant 643 
data were reproduced from reference 16).   644 
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